AIDX Revenue second quarter 2027 Y/Y Growth Comment
20/20 Biolabs, Inc. in the second quarter 2027 achieved Revenue of $ 0.73 millions compare to recorded in same quarter a year ago.
According to the results reported in the second quarter 2027, 20/20 Biolabs, Inc. achieved the best Revenue growth in IT Infrastructure industry. While 20/20 Biolabs, Inc.' s Revenue no change of 0% ranks overall at the positon no. in the second quarter 2027.
Revenue by Quarter for the Fiscal Years 2024, 2025, 2026, 2027
20/20 Biolabs,'s Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
106.73 %
51.67 %
-3.38 %
(Jun 30 2026)
AIDX's II. Quarter Q/Q Revenue Comment
20/20 Biolabs, Inc. achieved in the II. Quarter 2027 above company average sequential Revenue doubling of 108.73%, to $ 0.73 millions, from $0.35 millions in the first quarter. AIDX is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within IT Infrastructure industry 20/20 Biolabs, Inc. achieved highest sequential Revenue growth. While 20/20 Biolabs,'s Revenue growth quarter on quarter, overall rank is 0.
20/20 Biolabs, Inc. achieved in the II. Quarter 2027 above company average sequential Revenue doubling of 108.73%, to $ 0.73 millions, from $0.35 millions in the first quarter. AIDX is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within IT Infrastructure industry 20/20 Biolabs, Inc. achieved highest sequential Revenue growth. While 20/20 Biolabs,'s Revenue growth quarter on quarter, overall rank is 0.
20/20 Biolabs,'s 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending
12 Months Ending
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Revenue 12 Months Ending
$ 0.00
$ 0.00
$ 0.00
$ 0.00
$ 0.00
Y / Y Revenue Growth (TTM)
-
-
-
-
-
Year on Year Revenue Growth Overall
Ranking
#
#
#
#
#
Seqeuential Revenue Change (TTM)
-
-
-
-
-
Seq. Revenue Growth (TTM) Overall
Ranking
#
#
#
#
#
Cumulative Revenue growth Comment
In the period, 20/20 Biolabs,'s cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.
20/20 Biolabs, Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .
In the period, 20/20 Biolabs,'s cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.
20/20 Biolabs, Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .
About 20/20 Biolabs, Revenue Growth Rates (AIDX), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
